InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by ROWLAND LLOYD A, Conseiller Général. Insider active across 1 companies, notably CytomX Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. The latest transaction was filed on 2 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
022,500 shares0
Common Stock
SEC:0001567619-22-002524·
022,500 shares0
Common Stock
SEC:0001567619-22-002524:0·
2 of 2 declarations
About ROWLAND LLOYD A
ROWLAND LLOYD A is General Counsel at CytomX Therapeutics, Inc. In this role, he oversees the company's legal and regulatory affairs, ensuring compliance with applicable laws. His expertise in business law is crucial for risk management and protecting CytomX's interests. ROWLAND plays a key role in the company's legal strategy.
